AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIO-TECHNE Corp Director's Dealing 2013

Nov 4, 2013

30718_dirs_2013-11-04_501c33f8-2ac6-447a-8631-2b62c0960f4d.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2013-10-31

Reporting Person: HOLBROOK KAREN A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-10-31	Common Stock	A	1000	—	Acquired	1000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-10-31	Stock Option	$87.39	A	4000	Acquired	2023-10-30	Common Stock (4000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$66.90	2022-10-24	Common Stock (5000)	5000	Direct
Stock Option	$70.35	2021-10-26	Common Stock (5000)	5000	Direct
Stock Option	$61.46	2020-10-27	Common Stock (5000)	5000	Direct
Stock Option	$63.03	2019-10-28	Common Stock (5000)	5000	Direct
Stock Option	$65.47	2018-10-22	Common Stock (5000)	5000	Direct
Stock Option	$66.59	2017-10-24	Common Stock (5000)	5000	Direct
Stock Option	$57.06	2017-02-11	Common Stock (10000)	10000	Direct